Prognostic factors among patients with resected non-adenocarcinoma of the lung.

INTRODUCTION:Few studies have investigated the prognostic factors for non-adenocarcinoma of the lung. We retrospectively evaluated the prognostic factors on the basis of histological type of non-adenocarcinoma of the lung treated by pulmonary resection. METHODS:We enrolled 266 patients with non-adenocarcinoma of the lung in this retrospective study: 196 with squamous cell carcinoma (SCC) and 70 with non-SCC. RESULTS:Relapse-free survival (RFS) did not differ significantly between SCC and non-SCC patients (P=.33). For SCC patients, RFS differed significantly between patients who underwent wedge resection and non-wedge resection (P<.01), and between patients with Clavien¬-Dindo grade ≥3a and 0-2 postoperative complications (P<.01). For non-SCC patients, RFS rates were significantly different in the groups divided at neutrophil neutrophil-to-lymphocyte ratio =2.40 (P=.02), maximum standardized uptake value (SUVmax)=8.39 (P<.01), between patients with pathological stage (pStage) 0-I and with pathological stage more than II (P<.01). For SCC patients, male sex (P=.04), wedge resection (P=.01), and Clavien-Dindo grade ≥3a (P=.02) were significant factors for RFS in multivariate analysis. For non-SCC patients, neutrophil-to-lymphocyte ratio >2.40 (P<.01), SUVmax >8.39 (P=.01), and pStage ≥II (P=.03) were significant factors for RFS in multivariate analysis. CONCLUSION:RFS did not differ significantly differently between SCC and non-SCC patients. It is necessary to perform more than segmentectomy and to avoid severe postoperative complications for SCC patients. SUVmax might be an adaptation criterion of adjuvant chemotherapy for patients with non-adenocarcinoma and non-SCC of the lung.